Listen

Description

In this session, we had a brief update on infectious diseases. We also discussed advances in the management of metabolic dysfunction–associated steatotic liver disease, formerly known as Nonalcoholic fatty liver disease (NAFLD). 

Panelists:           

Host: 

Moderator: 

This session originally took place on September 26, 2025. A recording can be viewed here